11Scientific Ventures
11Scientific Ventures is focused on science-driven healthcare, biotech, and tech-bio opportunities.
11Scientific Ventures is the asset-focused investment platform within the broader 11Scientific ecosystem, applying deep scientific expertise and disciplined evaluation to identify and scale transformative healthcare and biotech innovations.
With a global presence, 11Scientific Ventures leverages its relationships and local knowledge in multiple locations around the world to provide high value to LPs, Co-Investors, Founders and Strategic Partners.
What we do
11Scientific Ventures invests in innovative clinical-to-commercial stage life sciences companies advancing transformative therapies to address critical unmet medical needs. We provide growth capital, strategic guidance, and operational support to accelerate the path from late-stage development through successful commercialization. Powered by the deep sector intelligence of the broader 11Scientific advisory platform, we bring scientific rigor, industry relationships, and execution expertise to build enduring life sciences companies.
Our Investment Approach
Advisory Insight
Uncovering white space and architecting actionable growth strategies
Capital Deployment
Designing and delivering high-impact investments with precision and speed
Innovation
Deploying capital into scalable innovation to advance healthcare solutions
Our Strengths
Integrated Model
Unified approach across strategy, capital, and execution
Sector Focus
Deep expertise in life sciences and healthcare platforms
Execution Agility
Ability to pivot quickly with scientific and market trends
Data-Driven Insights
Proprietary data and analytics guiding investment decisions
How We Evaluate Investments
We apply a rigorous, insight-driven approach to identify and scale transformative healthcare innovations.
01 — Breakthrough Focus
Technologies addressing critical gaps in care
​​
​
02 — Unmet Medical Need Alignment
Innovation calibrated to urgency and clinical relevance
​​
​
03 — Commercial & Market Validation
Market size, competition, and payer alignment assessed early
​​
​​
04 — Clear Path to Adoption
Assets with defined commercialization and scalable uptake
​
05 — Alpha
Identifying asymmetric value creation opportunities where scientific conviction and strategic edge generate outsized returns
11Scientific Ventures operates as the asset-focused investment platform within the broader 11Scientific ecosystem. Venture activities are pursued selectively where long-term asset value creation aligns with scientific and strategic expertise.